Sustained improved survival of patients with metastatic melanoma after the introduction of anti-PD-1-based therapies

The introduction of modern therapies improved the median survival of patients with metastatic melanoma (MM). Here, we determined the real-world impact of modern treatments on the long-term survival of MM.

Source: European Journal of Cancer - October 18, 2023 Category: Cancer & Oncology Authors: Aimilia Schina, Sidsel Pedersen, Anne-Louise Spenning, Olivia Kaas Laursen, Cecilia Pedersen, Charlotte Aaquist Haslund, Henrik Schmidt, Lars Bastholt, Inge Marie Svane, Eva Ellebaek, Marco Donia Tags: Original Research Source Type: research